Exact Mass: 350.1743

Exact Mass Matches: 350.1743

Found 17 metabolites which its exact mass value is equals to given mass value 350.1743, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Romergoline

4-({6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaen-4-yl}methyl)piperazine-2,6-dione

C20H22N4O2 (350.1743)


   

5-((2-(Diethylamino)ethyl)amino)-8-hydroxy-6H-imidazo[4,5,1-de]acridin-6-one

10-{[2-(diethylamino)ethyl]amino}-5-hydroxy-1,14-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-2(7),3,5,9,11,13(16),14-heptaen-8-one

C20H22N4O2 (350.1743)


   
   
   
   

9-Amino-N-(2-(4-morpholinyl)ethyl)-4-acridinecarboxamide

9-Amino-N-(2-(4-morpholinyl)ethyl)-4-acridinecarboxamide

C20H22N4O2 (350.1743)


   

Symadex

Symadex

C20H22N4O2 (350.1743)


D011838 - Radiation-Sensitizing Agents D000970 - Antineoplastic Agents

   

N-(3,4-dimethylphenyl)-2-(4-methylanilino)-6-oxo-4,5-dihydro-1H-pyrimidine-4-carboxamide

N-(3,4-dimethylphenyl)-2-(4-methylanilino)-6-oxo-4,5-dihydro-1H-pyrimidine-4-carboxamide

C20H22N4O2 (350.1743)


   

N-(2,4-dimethoxyphenyl)-2-(1-pyrrolidinyl)-4-quinazolinamine

N-(2,4-dimethoxyphenyl)-2-(1-pyrrolidinyl)-4-quinazolinamine

C20H22N4O2 (350.1743)


   

2-[(5-Methyl-1,3-benzoxazol-2-yl)amino]-5-spiro[1,6,7,8-tetrahydroquinazoline-4,1-cyclopentane]one

2-[(5-Methyl-1,3-benzoxazol-2-yl)amino]-5-spiro[1,6,7,8-tetrahydroquinazoline-4,1-cyclopentane]one

C20H22N4O2 (350.1743)


   

6-[4-[2-(4-morpholinyl)ethylamino]-1H-quinazolin-2-ylidene]-1-cyclohexa-2,4-dienone

6-[4-[2-(4-morpholinyl)ethylamino]-1H-quinazolin-2-ylidene]-1-cyclohexa-2,4-dienone

C20H22N4O2 (350.1743)


   

N-[(2S)-1-(1H-benzimidazol-2-ylamino)-3-methyl-1-oxobutan-2-yl]-3-methylbenzamide

N-[(2S)-1-(1H-benzimidazol-2-ylamino)-3-methyl-1-oxobutan-2-yl]-3-methylbenzamide

C20H22N4O2 (350.1743)


   

2-methoxy-6-[4-(4-methyl-1-piperazinyl)-1H-quinazolin-2-ylidene]-1-cyclohexa-2,4-dienone

2-methoxy-6-[4-(4-methyl-1-piperazinyl)-1H-quinazolin-2-ylidene]-1-cyclohexa-2,4-dienone

C20H22N4O2 (350.1743)


   

2-[(6-Methyl-1,3-benzoxazol-2-yl)amino]-5-spiro[1,6,7,8-tetrahydroquinazoline-4,1-cyclopentane]one

2-[(6-Methyl-1,3-benzoxazol-2-yl)amino]-5-spiro[1,6,7,8-tetrahydroquinazoline-4,1-cyclopentane]one

C20H22N4O2 (350.1743)


   

[(3aS,4R,9bS)-4-(hydroxymethyl)-8-[(E)-prop-1-enyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-pyrazin-2-ylmethanone

[(3aS,4R,9bS)-4-(hydroxymethyl)-8-[(E)-prop-1-enyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-pyrazin-2-ylmethanone

C20H22N4O2 (350.1743)


   

ABT-046

ABT-046

C20H22N4O2 (350.1743)


ABT-046 is a potent, selective, and orally active acyl CoA:diacylglycerol acyltransferase 1 (DGAT-1) inhibitor with IC50s of both 8 nM against human and mouse DGAT-1[1].

   

(3s,6z)-3-benzyl-6-{[5-(2-methylbut-3-en-2-yl)-1h-imidazol-4-yl]methylidene}-3h-pyrazine-2,5-diol

(3s,6z)-3-benzyl-6-{[5-(2-methylbut-3-en-2-yl)-1h-imidazol-4-yl]methylidene}-3h-pyrazine-2,5-diol

C20H22N4O2 (350.1743)